Serum cortisone and glucocorticoid receptor gene (NR3C1) polymorphism in human dysglycemia.,Hormones

当前位置： X-MOL 学术 › Hormones › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Serum cortisone and glucocorticoid receptor gene (NR3C1) polymorphism in human dysglycemia.
Hormones ( IF 2.4 ) Pub Date : 2020-04-17 , DOI: 10.1007/s42000-020-00196-9
Dandan Wei ₁ , Xue Liu ₁ , Wenqian Huo ₂ , Songcheng Yu ₃ , Linlin Li ₁ , Chongjian Wang ₁ , Zhenxing Mao ₁

Affiliation

Purpose

We aimed to explore the associations of serum cortisone and glucocorticoid receptor (GR) polymorphism with glucose metabolism and type 2 diabetes mellitus (T2DM) among Chinese adults.

Methods

A total of 2315 participants were included in the present study. Serum cortisone was measured by liquid chromatography-tandem mass spectrometry. Multivariable logistic regression and linear regression were employed to assess the associations between serum cortisone and different glucose metabolism status.

Results

Serum cortisone was positively associated with impaired fasting glucose (IFG) and T2DM ((Quartile 4 vs Quartile 1, odds ratio (OR) = 1.36, 95% confidence interval (CI) 1.01, 1.84, and OR = 2.08, 95% CI 1.50, 2.89, respectively)). A 100% increase in cortisone was associated with a 0.015 (95% CI 0.005, 0.025) mg/dl higher fasting plasma glucose (FPG), a 0.007 (95% CI 0.001, 0.013) higher glycosylated hemoglobin (HbA1c), a 0.4% (95% CI − 0.007, 0.000) lower HOMA2-IR, and a 58.1% (95% CI − 0.788, − 0.373) lower HOMA2-β. After stratification by genotype, the association between serum cortisone and T2DM was not significant in TT genotype carriers. In addition, at the higher concentrations of cortisone, TT genotype carriers had a lower FPG, HbA1c, and HOMA2-IR and a higher HOMA2-β than GG and GT carriers.